Alzheimers
-
{
- All
- News
- Web Stories
-
World's Youngest Alzheimer's Patient Was Just 19. Doctors Still Can't Explain Why
A 19-year-old in China has become the youngest person ever diagnosed with Alzheimer's disease, baffling doctors after no known genetic mutations were found to explain his rapid memory decline, which began when he was just 17.
-
Blood Test Can Help Detect Alzheimer's Signs Decades Before Symptoms, Finds Lancet Study
The findings demonstrate the potential of detecting early-stage AD among middle-aged adults using blood tests.
-
What I Tell Families When They Ask: Should We Put My Parent On The New Drug, Lormalzi?
Lormalzi is not a cure. I say this not to take away hope, but because understanding this is what allows families to make decisions rooted in reality rather than desperation.
-
Who Should Take Lormalzi? Alzheimer's Expert Explains Benefits And Risks
Neurologists say Lormalzi (donanemab), India's newly launched Alzheimer's therapy, may help slow cognitive decline in carefully selected patients with early disease. Experts explain who may benefit, who should avoid it, and the risks involved.
-
Eli Lilly Launches Alzheimer's Drug Lormalzi Priced At Rs 91,688 Per Vial In India
Eli Lilly has launched Lormalzi (donanemab) in India for early Alzheimer's disease at Rs91,688 per vial. The once-monthly therapy targets amyloid plaques and may help slow cognitive decline in eligible patients with mild symptoms.
-
Study Finds Three Different Patterns Of Cognitive Decline In Alzheimer's Disease
A study has revealed three types of cognitive decline in Alzheimer's disease -- stable or no change, slow decline, and fast decline.
-
Is Vitamin D Deficiency A Risk Factor For Alzheimer's Disease? Study Answers
The researchers found that individuals with very low vitamin D levels were much more likely to develop dementia or Alzheimer's disease compared to those with normal levels.
-
Smell Test For Alzheimer's Disease: Can It Detect Risk Years Before Symptoms?
Scientists are exploring smell tests as an early indicator of Alzheimer's risk, detecting brain changes years before memory loss occurs.
-
Alzheimer's Amyloid-Targeting Drugs Show No Clear Clinical Benefit: Review
Drugs designed to treat Alzheimer's disease by targeting amyloid proteins was seen in high amounts in patients' brains, but it has no clinically meaningful positive effects, according to a new review of previously published studies has found.
-
Alzheimer's Detection Through Plasma Protein Changes Offer Clues To Early Diagnosis: Study
A new type of blood test that analyses the folding of amino acids rather than their amounts may detect earliest biological signs of Alzheimer's disease, according to a study.
-
Study Reveals How Physical Activity Repairs The Blood-Brain Barrier To Improve Memory And Protect Brain From Alzheimer's
Researchers at UC San Francisco have identified a biological process that may explain why exercise sharpens thinking and memory.
-
Peripheral Retina May Help Detect Early Signs Of Alzheimer's Disease Before Brain Damage: Study
The study, published in the Journal of Alzheimer's Disease, was conducted in mouse models and revealed how 'Muller glia', or retinal support cells
-
Air Pollution Increases Risk Of Alzheimer Disease, Finds New Study
Longterm air pollution exposure raises Alzheimer's risk directly, major US study finds, highlighting urgent need to protect brain health in older adults.
-
Early Alzheimer's Detection Is Changing How Indian Families Plan Daily Life; Doctor Explains Shift
Forgetting routes and repeating questions may not be normal ageing. Early Alzheimer's detection is helping Indian families prepare emotionally, medically and financially, says neurologist Dr Renjen.
-
Reading, Writing And Learning New Languages May Delay Alzheimer's By Up To 5 Years
The new study says that engaging in activities like reading, writing and learning a language can help to lower the risk of Alzheimer's disease and slower cognitive decline.
-
World's Youngest Alzheimer's Patient Was Just 19. Doctors Still Can't Explain Why
A 19-year-old in China has become the youngest person ever diagnosed with Alzheimer's disease, baffling doctors after no known genetic mutations were found to explain his rapid memory decline, which began when he was just 17.
-
Blood Test Can Help Detect Alzheimer's Signs Decades Before Symptoms, Finds Lancet Study
The findings demonstrate the potential of detecting early-stage AD among middle-aged adults using blood tests.
-
What I Tell Families When They Ask: Should We Put My Parent On The New Drug, Lormalzi?
Lormalzi is not a cure. I say this not to take away hope, but because understanding this is what allows families to make decisions rooted in reality rather than desperation.
-
Who Should Take Lormalzi? Alzheimer's Expert Explains Benefits And Risks
Neurologists say Lormalzi (donanemab), India's newly launched Alzheimer's therapy, may help slow cognitive decline in carefully selected patients with early disease. Experts explain who may benefit, who should avoid it, and the risks involved.
-
Eli Lilly Launches Alzheimer's Drug Lormalzi Priced At Rs 91,688 Per Vial In India
Eli Lilly has launched Lormalzi (donanemab) in India for early Alzheimer's disease at Rs91,688 per vial. The once-monthly therapy targets amyloid plaques and may help slow cognitive decline in eligible patients with mild symptoms.
-
Study Finds Three Different Patterns Of Cognitive Decline In Alzheimer's Disease
A study has revealed three types of cognitive decline in Alzheimer's disease -- stable or no change, slow decline, and fast decline.
-
Is Vitamin D Deficiency A Risk Factor For Alzheimer's Disease? Study Answers
The researchers found that individuals with very low vitamin D levels were much more likely to develop dementia or Alzheimer's disease compared to those with normal levels.
-
Smell Test For Alzheimer's Disease: Can It Detect Risk Years Before Symptoms?
Scientists are exploring smell tests as an early indicator of Alzheimer's risk, detecting brain changes years before memory loss occurs.
-
Alzheimer's Amyloid-Targeting Drugs Show No Clear Clinical Benefit: Review
Drugs designed to treat Alzheimer's disease by targeting amyloid proteins was seen in high amounts in patients' brains, but it has no clinically meaningful positive effects, according to a new review of previously published studies has found.
-
Alzheimer's Detection Through Plasma Protein Changes Offer Clues To Early Diagnosis: Study
A new type of blood test that analyses the folding of amino acids rather than their amounts may detect earliest biological signs of Alzheimer's disease, according to a study.
-
Study Reveals How Physical Activity Repairs The Blood-Brain Barrier To Improve Memory And Protect Brain From Alzheimer's
Researchers at UC San Francisco have identified a biological process that may explain why exercise sharpens thinking and memory.
-
Peripheral Retina May Help Detect Early Signs Of Alzheimer's Disease Before Brain Damage: Study
The study, published in the Journal of Alzheimer's Disease, was conducted in mouse models and revealed how 'Muller glia', or retinal support cells
-
Air Pollution Increases Risk Of Alzheimer Disease, Finds New Study
Longterm air pollution exposure raises Alzheimer's risk directly, major US study finds, highlighting urgent need to protect brain health in older adults.
-
Early Alzheimer's Detection Is Changing How Indian Families Plan Daily Life; Doctor Explains Shift
Forgetting routes and repeating questions may not be normal ageing. Early Alzheimer's detection is helping Indian families prepare emotionally, medically and financially, says neurologist Dr Renjen.
-
Reading, Writing And Learning New Languages May Delay Alzheimer's By Up To 5 Years
The new study says that engaging in activities like reading, writing and learning a language can help to lower the risk of Alzheimer's disease and slower cognitive decline.
